Stay updated with breaking news from Pentech Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biopharma companies are harnessing AI tools for multiple aspects of drug development such as identifying drug development targets, modeling a drug's effect on the body, and more.
The FTC’s antagonism of Big Tech sets companies up for “painfully long processes” for dealmaking, says Battery Ventures’s Chelsea Stoner.
Nvidia, Northwell Health and others saw an influx in digital health dollars this week.
Causality uses machine learning to automate the prior, heavily manual processes of biomedical research and drug discovery.
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!